RHYTHM PHARMACEUTICALS, INC.

By person

15 insiders · 57 transactions

31.1×

David P. Meeker holds 31.1 times base salary in stock. $25.17M of shares against $807.69K in salary for 2025.

Salary from the company's own proxy. The shares are what David P. Meeker last reported holding, valued at $105.19, the price Common Stock was last bought or sold at on the open market here, on 14 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Lee Jennifer Kayden

EVP, Head of North America

—

$8.90M (1) scheduled

−$8.90M

0.0000%

$0.00

−100.0%

Smith Hunter C

Chief Financial Officer

—

$8.84M (26) scheduled

−$8.84M

114,024

0.1656%

$11.99M

+16.4%

Mazabraud Yann

EVP, Head of International

—

$6.62M (6) scheduled

−$6.62M

55,655

0.0808%

$5.85M

+59.6%

Meeker David P

President and CEO

—

$5.13M (5) scheduled

−$5.13M

239,258

0.3475%

$25.17M

+32.3%

TETRAULT LYNN A.

Director

—

$3.71M (1) scheduled

−$3.71M

11,712

0.0170%

$1.23M

+290.4%

Shulman Joseph

Chief Technical Officer

—

$3.67M (6) scheduled

−$3.67M

15,915

0.0231%

$1.67M

—

Cramer Pamela J.

Chief Human Resources Officer

—

$2.99M (4) scheduled

−$2.99M

29,376

0.0427%

$3.09M

+117.6%

German Christopher Paul

Corporate Controller & CAO

—

$930.92K (2) scheduled

−$930.92K

0.0000%

$0.00

−100.0%

Garfield Alastair

Chief Scientific Officer

—

$912.70K (4) scheduled

−$912.70K

2,295

0.0033%

$241.41K

—

Mathers Edward T

Director

—

21,168

0.0307%

$2.23M

+141.3%

Arbuckle Stuart A

Director

—

11,712

0.0170%

$1.23M

+290.4%

MCGIRR DAVID W J

Director

—

11,712

0.0170%

$1.23M

+290.4%

JEAN CHRISTOPHE

Director

—

11,712

0.0170%

$1.23M

+290.4%

GOOD JENNIFER L

Director

—

11,712

0.0170%

$1.23M

+290.4%

Bedrosian Camille L

Director

—

7,000

0.0102%

$736.33K

+133.3%

RHYTHM PHARMACEUTICALS, INC.

By person

Individual transactions

What was left out